CNN’s Brianna Keilar discusses how Fox News is enabling President Trump’s 2020 election conspiracy theories despite them lacking evidence and plausibility.
Category: November 2020
The federal government unveiled more financial support in response to the second wave of the COVID-19 pandemic, but the latest projections show that Canada’s national deficit is projected to hit a new high — at least $381.6 billion this fiscal year.
The pandemic has had an impact on all Canadians, but it’s hit those on a low income especially hard. There’s now a growing concern that the number of homeless people in Canada may go up. Katherine Ward has the story of a man from Toronto who is struggling to get the help he needs.
December is just days away and the weather is getting colder, but for Canada’s homeless population it makes an already difficult life even more challenging. This is especially challenging when cities don’t always see eye-to-eye on the methods on how to keep the homeless warm such as setting up camps in parks. But as Mike Armstrong explains, Montreal is taking a new approach on how to get people off the streets.
The British government has warned that a third wave of coronavirus is possible in the new year — if restrictions are relaxed too far. It comes as Prime Minister Boris Johnson faces a rebellion by some of his own Conservative MPs, who believe some of the rules planned after the latest national lockdown in England is lifted go too far. Meanwhile the UK has bought another two million doses of the Moderna coronavirus vaccine. It’s one of the three vaccines that are being put forward for regulatory approval after clinical trials. Mishal Husain presents BBC News at Ten reporting by political correspondent Iain Watson and science editor David Shukman.
CNN’s Amara Walker, Carl Bernstein and Brian Stelter discuss President Trump’s admission during a Fox News interview that “it’s hard” to get cases to the Supreme Court and how Trump’s continued legal challenges could undermine future election processes.
Dr. Anthony Fauci, Director, National Institute of Allergy and Infectious Diseases, talks to Chuck Todd about the ongoing Covid spike and how a vaccine will be distributed, during an interview with Meet the Press.
Joe Biden has been running for public office for nearly 50 years. For the last 13 of them, NBC News’ Mike Memoli has been in the front row – covering Biden as the Vice President and then as a candidate through this historic election season. Here’s a look at Biden’s path to the presidency, through his eyes.
‘We’re here because of Trump’s failed policy’: Analyst on killing of Iran’s top scientist
Coronavirus is ripping through indigenous communities in the Amazon rainforest. Now, some are starting to fight back. Filmed by: Fernando Crispim, Jose Monteiro. Produced by: Mohamed Madi, Ana Terra Athayde, Camilla Mota.
Indian Prime Minister Narendra Modi toured three of the nation’s leading vaccine development and manufacturing sites on Saturday as coronavirus cases continue to soar. India has recorded 9.35 million total COVID-19 infections, second only to the United States. It reported 41,322 new cases and 485 deaths on Saturday. The western state of Maharashtra, which is home to India’s financial hub, Mumbai, has been particularly hard hit by the virus. Its tally of 1.68 million cases is higher than countries such as Spain, Italy and the United Kingdom. Modi conducted a whirlwind three-city tour and visited the Zydus Cadila facility in the western city of Ahmedabad, Bharat Biotech’s facilities in the southern hub of Hyderabad and the Serum Institute of India’s sprawling campus in the western city of Pune. Following the visits Modi said India’s role in developing vaccines was a global benefit and he was pleased with the rapid progress being made. “It is India’s duty to assist other countries, including the nations in our neighbourhood, in the collective fight against the virus,” Modi said in a statement. The companies are testing homegrown vaccine options, as well as working on trials of vaccines being developed overseas. Serum Institute, the world’s largest vaccine manufacturer, has partnered with global players including AstraZeneca and Novavax Inc to run domestic trials on their vaccine candidates and produce the vaccines, if they secure approvals.